Search

Your search keyword '"Venous thrombosis -- Drug therapy -- Research"' showing total 7 results
Start Over Descriptor "Venous thrombosis -- Drug therapy -- Research"
7 results on '"Venous thrombosis -- Drug therapy -- Research"'

1. Findings from University of Queensland Yields New Findings on Cancer (Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolisms: a Systematic Review and Network Meta-analysis)

Subjects
Drug therapy, Usage, Complications and side effects, Research, Cancer -- Complications and side effects -- Research, Thromboembolism -- Drug therapy -- Research, Cancer research, Anticoagulants -- Research -- Usage, Venous thrombosis -- Drug therapy -- Research, Oncology, Experimental, Anticoagulants (Medicine) -- Research -- Usage
Abstract

2022 APR 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Cancer are presented in a new report. According to [...]

Published
2022

3. Antidote for new anticoagulants studied

Author

Garrett, Anna D.

Subjects
PRT4445 (Medication) -- Testing, Testing, Drug therapy, Research, Dosage and administration, Product development, Atrial fibrillation -- Drug therapy -- Research, Rivaroxaban -- Dosage and administration, Venous thrombosis -- Drug therapy -- Research, Antidotes -- Testing, Pharmaceutical industry -- Product development, Dabigatran etexilate -- Dosage and administration
Abstract

A 'universal antidote' for factor Xa inhibitors has entered phase 2 studies in which the drug, currently called PRT4445 (Portola Pharmaceuticals), will be given to healthy volunteers who have been [...]

Published
2013

4. Pneumococcal vaccines; use of rivaroxaban for DVT and PE

Author

DeDea, Larissa

Subjects
Drug therapy, Research, Dosage and administration, Health aspects, Pulmonary embolism -- Drug therapy -- Research, Pneumococcal vaccines -- Health aspects -- Research, Rivaroxaban -- Dosage and administration -- Research, Venous thrombosis -- Drug therapy -- Research, Pneumococcal vaccine -- Health aspects -- Research
Abstract

* WHAT ARE THE DIFFERENT TYPES OF PNEUMOCOCCAL VACCINES? The pneumococcal vaccine was developed to provide protection against infections caused by Streptococcus pneumoniae, or pneumococcus. It is available in two [...]

Published
2012

5. Meeting reporter: updates from key conferences

Subjects
Drug therapy, Research, Dosage and administration, Anticoagulants -- Dosage and administration -- Research, Venous thrombosis -- Drug therapy -- Research, Anticoagulants (Medicine) -- Dosage and administration -- Research
Abstract

ORLANDO -- Dutch researchers reported good results for a potential alternative to standard treatment for deep venous thrombosis (DVT). At the annual meeting of the American Society of Hematology (ASH), [...]

Published
2007

6. Subcutaneous unfractionated heparin: ready for prime time?

Author

Ebbert, Jon O. and Tangalos, Eric G.

Subjects
Drug therapy, Research, Dosage and administration, Heparin -- Dosage and administration -- Research, Venous thrombosis -- Drug therapy -- Research, Pain management -- Research, Pain -- Care and treatment
Abstract

The Problem A 52-year-old nurse with a history of breast cancer treated with mastectomy presents to you with a 3-day history of leg pain and swelling. She has calf tenderness [...]

Published
2006

7. AstraZeneca Pharmaceuticals LP

Subjects
AstraZeneca Pharmaceuticals L.P. -- Research, Exanta (Medication) -- Testing -- Evaluation, Testing, Drug therapy, Evaluation, Research, Pulmonary embolism -- Drug therapy -- Research, Pharmaceutical research -- Evaluation -- Research, Venous thrombosis -- Drug therapy -- Research
Abstract

AstraZeneca Pharmaceuticals LP (Wilmington, DE) announced the results of a randomized, double-blind, Phase 3 study comparing Exanta (ximelagatran, formerly known as H376/95) with warfarin for the prevention of deep vein [...]

Published
2001

Catalog

Books, media, physical & digital resources
See catalog results